dc.creatorMarinelli, Raul Alberto
dc.creatorMarrone, Julieta
dc.date.accessioned2018-07-18T22:08:01Z
dc.date.available2018-07-18T22:08:01Z
dc.date.created2018-07-18T22:08:01Z
dc.date.issued2017-01
dc.identifierMarinelli, Raul Alberto; Marrone, Julieta; Aquaporin gene therapy for cholestasis; John Wiley & Sons Inc; Hepatology (Baltimore, Md.); 65; 1; 1-2017; 387-388
dc.identifier0270-9139
dc.identifierhttp://hdl.handle.net/11336/52635
dc.identifierCONICET Digital
dc.identifierCONICET
dc.description.abstractThis is regarding the editorial “Aquaporin gene therapy for disorders of cholestasis?” by Tradtrantip and Verkman.(1) We thank the authors for their comments in our recent studies.(2,3) Nevertheless, we believe that an analysis of the role of aquaporins (AQPs) in hepatocyte canalicular water transport and bile secretion should take into account several published contributions that were not cited in the editorial.
dc.languageeng
dc.publisherJohn Wiley & Sons Inc
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1002/hep.28734
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.28734
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectBile Salt Export Pump
dc.subjectAdenovirus
dc.subjectBile Acids
dc.subjectCanalicular Lipid Microdomains
dc.titleAquaporin gene therapy for cholestasis
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución